Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
What to avoid during administration Certain conditions reduce AOD-9604 effectiveness regardless of dose or timing
The metabolism of myo-inositol by the human kidney
Self-administering BPC-157 without medical supervision introduces risks related to incorrect dosing, improper injection technique, and the use of unverified products
Use sterile syringes, needles, and bacteriostatic water to minimise the risk of contamination
Last medically reviewed: 2026-06-08 by GLP3 Planner editorial
US$ 20.03
US$ 29.63
US$ 27.83
US$ 21.10
US$ 23.48
US$ 23.79
